Of note, T cells from patients with systemic lupus erythematosus (SLE) exhibited significant resistance to galectin-1 binding, which might be due to glycosylation of cell surface glycan altered by the ratio of sialyltransferases and neuraminidase 1. The gene discussed is NEU1; the disease is systemic lupus erythematosus.